Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/06/2012US8129426 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof
03/06/2012US8129425 Contacting cell with hedgehog antagonist; moderator of cell proliferative, cell differentiation
03/06/2012US8129424 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
03/06/2012US8129423 1-Adamantan-2-yl-3-benzyl-1,3-dihydro-imidazol-2-one; 11beta-hydroxysteroid dehydrogenases (11beta-HSD) inhibitor; antidiabetic, hypotensive, hypoglycemic agent; resist hyperglycemia provoked by obesity or stress;
03/06/2012US8129422 Methods and compositions for increasing the anaerobic working capacity in tissues
03/06/2012US8129421 Method for preparing 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]-benzoic acid
03/06/2012US8129418 Macrocyclic compounds and methods of treatment
03/06/2012US8129417 Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
03/06/2012US8129416 Biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
03/06/2012US8129414 Non-competitive NMDA receptor antagonists
03/06/2012US8129413 Crystalline forms of MC4R agonist and process for synthesis
03/06/2012US8129412 Hydantoin derivatives useful as metalloproteinase inhibitors
03/06/2012US8129411 Organic compounds
03/06/2012US8129410 Benzisoxazole piperidine compounds and methods of use thereof
03/06/2012US8129408 Pharmaceutical composition for piperidinoalkanol compounds
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129406 Nonpeptide inhibitors of matrix metalloproteinases
03/06/2012US8129405 Quinuclidine derivatives and medicinal compositions containing the same
03/06/2012US8129404 Compounds and uses thereof
03/06/2012US8129403 e.g. 2-[9-(5-Cyclopropyl-1H-pyrazol-3-yl)-6-methyl-9H-purin-2-ylamino]-2-(4-fluorophenyl)ethanol; tropomyosin-related kinases (Trk's) inhibitor; anticarcinoganic agent; solid tumors and leukemia
03/06/2012US8129402 Screening molecules with anti-prion activity: kits, methods and screened molecules
03/06/2012US8129401 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
03/06/2012US8129400 Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same
03/06/2012US8129399 Aminopyrimidines useful as kinase inhibitors
03/06/2012US8129398 HIV integrase inhibitors
03/06/2012US8129397 Substituted thieno[2,3-d]pyrimidines as AMPA modulators
03/06/2012US8129395 4,5-disubstituted-2-aryl pyrimidines
03/06/2012US8129394 Heteroaryl-substituted imidazole compounds and uses thereof
03/06/2012US8129393 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
03/06/2012US8129391 N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
03/06/2012US8129390 Carboxamide, sulfonamide and amine compounds and methods for using the same
03/06/2012US8129389 Substituted oxindole derivatives, medicaments containing the latter and use thereof
03/06/2012US8129388 Therapeutic agents useful for treating pain
03/06/2012US8129387 Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors
03/06/2012US8129386 Fused azole-pyrimidine derivatives
03/06/2012US8129385 Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness
03/06/2012US8129384 Imidazo[1,2-a]pyrazines as orexin receptor antagonists
03/06/2012US8129383 Administering tablets containing less than 0.5 mg; uninterrupted dosage cycles; antiinflammatory agent; nontoxic; side effect reduction; antiarthritic agents; psoriasis, multiple, sclerosis, Crohn's disease, Lupus, Graft versus host disease
03/06/2012US8129382 Compounds, methods and pharmaceutical compositions for inhibiting PARP
03/06/2012US8129381 Caspase inhibitors and uses thereof
03/06/2012US8129380 Phthalazinone derivatives
03/06/2012US8129379 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/06/2012US8129378 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
03/06/2012US8129377 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors
03/06/2012US8129376 Piperidine derivatives as inhibitors of stearoyl-CoA desaturase
03/06/2012US8129375 Isoindoline compounds and methods of their use
03/06/2012US8129374 Method of using imidazolothiazole compounds for the treatment of disease
03/06/2012US8129373 Carbonyl compounds
03/06/2012US8129372 Compounds having NPY Y5 receptor antagonistic activity
03/06/2012US8129371 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors
03/06/2012US8129370 Use of oxicam compounds
03/06/2012US8129369 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof
03/06/2012US8129368 5,6-dihydro-1H-pyridin-2-one compounds
03/06/2012US8129367 Compounds for the treatment of Hepatitis C
03/06/2012US8129366 VLA-4 inhibitory drug
03/06/2012US8129365 Water-soluble, fluorescent compounds for detection of potassium ions
03/06/2012US8129364 Formulations and methods for treating rhinosinusitis
03/06/2012US8129363 Method for obtaining conjugated estrogen mixtures from pregnant mare urine and use of a macroporous resin in the method
03/06/2012US8129362 Combination/association of adapalene and benzoyl peroxide for treating acne lesions
03/06/2012US8129361 Amine compound and pharmaceutical use thereof
03/06/2012US8129360 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
03/06/2012US8129359 Composition and method for treating post-surgical pain
03/06/2012US8129358 Substituted pyrazole and triazole compounds as KSP inhibitors
03/06/2012US8129357 N6-(4-hydroxybenzyl)adenosine; Gastrodia extract; neurodegenerative Huntington's disease; trinucleotide repeat disease; hypoglycemic; neurological antiinflammatory; amination of 6-chloropurine ribonucleoside with 4-hydroxybenzylamine; condensation of adenosine with 4-methoxybenzoyl chloride
03/06/2012US8129356 Bmx mediated signal transduction in irradiated vascular endothelium
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/06/2012US8129354 Alzheimer's, Parkinson's, multiple sclerosis, schizophrenia, epilepsy, depression and pain
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129350 administering flavonoids selected from luteolin, apigenin, tricin or their derivatives with food to delay digestion of carbohydrates
03/06/2012US8129340 Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof
03/06/2012US8129333 Antigen delivery vectors and constructs
03/06/2012US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
03/06/2012US8129172 Growing Thraustochytrium, Schizochytrium, and/or mixtures in a culture medium containing a non-chloride sodium salt, e.g., sodium sulfate; microfloral biomass; aquaculture of larval shrimp, rotifers, molluscs; extruded food with flaxseed meal
03/06/2012US8129144 Papilloma pseudovirus and preparation
03/06/2012US8128972 Compositions and methods for enhancing and treating female sexual response
03/06/2012US8128966 Modified pectins, compositions and methods related thereto
03/06/2012US8128964 Transdermal pharmaceutical delivery composition
03/06/2012US8128959 Polymeric pharmaceutical agent for treatment of cancer and method for production of the same
03/06/2012US8128958 no restriction of food ingestion in its dosage; reduced side effects; tamsulosin
03/06/2012US8128957 Modified release compositions of at least one form of tramadol
03/06/2012US8128955 Food compositions containing creatine
03/06/2012US8128954 Biodegradable drug-polymer delivery system
03/06/2012US8128950 Paper product with disinfecting properties
03/06/2012US8128945 Drug delivery system targeting to estrogen receptor over-expressed cells
03/06/2012US8128944 RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
03/06/2012US8128943 Use of oxazole derivatives for controlling fish parasites
03/06/2012US8128942 Anti-sepsis conjugate vaccine
03/06/2012US8128938 Influenza virus vaccine composition and methods of use
03/06/2012US8128929 Antibodies against PDGFRa
03/06/2012US8128922 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
03/06/2012US8128920 IL-18BPb and IL-18BPd ( interleukin-18 binding protein isoform b and d ) that does not bind IL-18 for treating chronic neurodegenerative disease is selected from multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) or amyotrophic lateral sclerosis (ALS)
03/06/2012US8128909 Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
03/06/2012US8128905 Stabilized uncoated particles of reversed liquid crystalline phase materials
03/06/2012CA2644152C Soybean-germ oil and method for the production of germ-enriched soybean material
03/06/2012CA2623024C Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives
03/06/2012CA2613041C Agent for improving insulin resistance
03/06/2012CA2611441C Solution for tissue adhesion prevention and method for tissue adhesion prevention
03/06/2012CA2604017C Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
03/06/2012CA2560694C Progesterone receptor modulators
03/06/2012CA2550892C Spirocyclic cyclohexane derivatives
1 ... 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 ... 7860